Sepehrizadeh Zargham, Sahebgharani Mousa, Ahmadi Shamseddin, Shapourabadi Mina Bahrololoumi, Bozchlou Saeed Hashemi, Zarrindast Mohammad-Reza
Department of Pharmaceutical Biotechnology, Faculty of Pharmacy, University of Tehran, Tehran, Iran.
Pharmacology. 2008;81(4):333-43. doi: 10.1159/000122959. Epub 2008 Apr 3.
This study was designed to evaluate the effect of repeated morphine treatment on rat behavioral responses. In the genetic section, the mRNA expression of NMDA receptor subunits (NR1 and NR2A) was measured in certain areas of the male rat brain (striatum, prefrontal cortex, hippocampus, hypothalamus and amygdala). In the behavioral section, the effect of repeated morphine treatment on animal models such as locomotion, oral stereotypy, and state-dependent memory in a passive avoidance test was evaluated in the presence or absence of MK801 (NMDA receptor antagonist). Our results showed that chronic morphine treatment, followed by a 7-day (but not 24-hour) washout period, potentiated the effect of test doses of morphine, which is referred to as behavioral sensitization. Meanwhile, pretreatment of animals with MK801 (0.1 and 0.25 mg/kg), 30 min before a test dose of morphine (5 mg/kg), failed to attenuate the locomotion and oral stereotypy in the behavioral sensitization state. Interestingly, a higher dose of MK801 (0.25 mg/kg) decreased memory retrieval induced by morphine (2.5 mg/kg) in state-dependent memory. This effect may be due to the intrinsic motor enhancer property of higher doses of MK801, rather than the blockade of NMDA receptors. It can be concluded that MK801 does not affect morphine-induced behavioral sensitization in the expression phase. In the genetic section of the study, results of quantitative real-time RT-PCR clearly indicated that morphine sensitization increased the expression of NMDA receptor subunits mRNA in the amygdala (NR1 by 104% and NR2A by 85%), while the other areas of the brain were unaffected. Maenwhile, no change in the mRNA levels was observed in non-sensitized animals (chronic morphine treatment followed by a 24-hour washout period). In summary, the present study indicates that repeated morphine treatment followed by long-term (7-day washout) induces behavioral sensitization and causes a delayed increase in mRNA levels of NMDA receptor subunits in the rat amygdala. Meanwhile, it has previously been reported that the amygdala is involved in behavioral sensitization. Thus, it can be concluded that the increase in NMDA receptor expression is associated with morphine-induced behavioral sensitization.
本研究旨在评估重复给予吗啡对大鼠行为反应的影响。在基因部分,测定了雄性大鼠脑内特定区域(纹状体、前额叶皮质、海马体、下丘脑和杏仁核)中NMDA受体亚基(NR1和NR2A)的mRNA表达。在行为部分,在有或没有MK801(NMDA受体拮抗剂)存在的情况下,评估了重复给予吗啡对动物模型(如运动、口部刻板行为和被动回避试验中的状态依赖性记忆)的影响。我们的结果表明,慢性吗啡处理后经过7天(而非24小时)的洗脱期,可增强试验剂量吗啡的作用,这被称为行为敏化。同时,在给予试验剂量吗啡(5mg/kg)前30分钟,用MK801(0.1和0.25mg/kg)预处理动物,未能减弱行为敏化状态下的运动和口部刻板行为。有趣的是,更高剂量的MK801(0.25mg/kg)降低了吗啡(2.5mg/kg)在状态依赖性记忆中诱导的记忆恢复。这种效应可能是由于更高剂量的MK801具有内在的运动增强特性,而非对NMDA受体的阻断作用。可以得出结论,MK801在表达阶段不影响吗啡诱导的行为敏化。在该研究的基因部分,定量实时RT-PCR结果清楚地表明,吗啡敏化增加了杏仁核中NMDA受体亚基mRNA的表达(NR1增加104%,NR2A增加85%),而脑内其他区域未受影响。同时,在未敏化动物(慢性吗啡处理后经过24小时洗脱期)中未观察到mRNA水平的变化。总之,本研究表明,重复给予吗啡后经过长期(7天洗脱)诱导行为敏化,并导致大鼠杏仁核中NMDA受体亚基的mRNA水平延迟升高。同时,此前已有报道称杏仁核参与行为敏化。因此,可以得出结论,NMDA受体表达的增加与吗啡诱导的行为敏化相关。